Bephenium hydroxynaphthoate
![]() | |
| Clinical data | |
|---|---|
| Pregnancy category |
|
| Routes of administration | Oral |
| ATC code | P02CX02 (WHO) |
| Pharmacokinetic data | |
| Bioavailability | <1% |
| Excretion | Renal (negligible) |
| Identifiers | |
| |
| CAS Number |
7181-73-9 3818-50-6 (hydroxynaphtoate) |
| PubChem (CID) | 19667 |
| ChemSpider |
18524 |
| UNII |
47RU9546DX |
| ChEMBL |
CHEMBL1673148 |
| Chemical and physical data | |
| Formula | C17H22NO+ |
| Molar mass | 256.36 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Bephenium hydroxynaphthoate (INN, trade names Alcopara, Alcopar, Befenium, Debefenium, Francin, Nemex) is an anthelmintic agent formerly used in the treatment of hookworm infections and ascariasis.[1][2]
Bephenium is not FDA-approved and is not available in the United States.[3]
References
- ↑ Sweetman S, ed. (2009). Martindale: The complete drug reference (36th ed.). London: Pharmaceutical Press. p. 143. ISBN 978-0-85369-840-1.
- ↑ Jayewardene G, Ismail MM, Wijayaratnam Y (July 1960). "Bephenium hydroxynaphthoate in treatment of ascariasis". Br Med J. 2 (5194): 268–71. doi:10.1136/bmj.2.5194.268. PMC 2097409
. PMID 14406934. - ↑ Pham PA (March 19, 2009). "Bephenium hydroxynaphthoate". Point-of-Care Information Technology ABX Guide. Johns Hopkins University. Retrieved on March 25, 2011.
This article is issued from Wikipedia - version of the 5/22/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
